FDA Law Blog: Biosimilars

FEBRUARY 11, 2024

The regulated cannabis marketplace brings in billions of dollars in revenue into state and federal governments, with predictions that cannabis sales will exceed $53 billion by 2027. Studies have found that marijuana access has public health benefits by reducing the rates of opioid use and opioid deaths.

Regulations 59

Regulations Production Drugs FDA Approval 59

Drug Target Review

MARCH 20, 2025

These studies, anticipated to complete in 2027, could open doors for abelacimab’s approval in this indication. “We anticipate ASTER will complete in early 2027 and could form the basis for approval in the treatment and prevention of venous thrombotic events in patients with cancer,” Bloomfield said. .

Therapies 52

Therapies Clinical Development Trials FDA 52

The Pharma Data

MAY 4, 2021

down 21%, driven by a negative impact from the COVID-19 pandemic resulting in a decline in patient visits to doctors for preventative health purposes, as well as the loss of patent protection in the U.S. RE47,739 for Ibrance by more than four years until March 2027. Hospital products, which grew 10% operationally to $2.3

Vaccine 40

Vaccine Production FDA Clinical Trials 40